Efficacy of 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting response to second-generation androgen receptor axis-targeted therapy, and the prognosis in metastatic hormone-refractory prostate cancer patients

Psma Pet ◽

Pet Ct ◽

Faculty Opinions recommendation of Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726129005.793514252 ◽

2016 ◽

Author(s):

Badrinath Konety

Keyword(s):

Prostate Cancer ◽

Targeted Therapy ◽

Cancer Patients ◽

Curative Treatment ◽

Prospective Comparison ◽

Psma Pet ◽

Pet Ct

Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy

Journal of Nuclear Medicine ◽

10.2967/jnumed.115.160382 ◽

2015 ◽

Vol 56 (8) ◽

pp. 1185-1190 ◽

Cited By ~ 292

Author(s):

J. J. Morigi ◽

P. D. Stricker ◽

P. J. van Leeuwen ◽

R. Tang ◽

B. Ho ◽

...

Keyword(s):

Prostate Cancer ◽

Targeted Therapy ◽

Cancer Patients ◽

Curative Treatment ◽

Prospective Comparison ◽

Psma Pet ◽

Pet Ct

Correlations between whole body volumetric parameters of 68Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients

Annals of Nuclear Medicine ◽

10.1007/s12149-021-01594-8 ◽

2021 ◽

Vol 35 (5) ◽

pp. 540-548

Author(s):

Özgen Ahmet Yildirim ◽

Cihan Gündoğan ◽

Canan Can ◽

Kerem poyraz ◽

Erkan Erdur ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Whole Body ◽

Psma Pet ◽

Pet Ct

Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients

British Journal of Cancer ◽

10.1038/sj.bjc.6604152 ◽

2008 ◽

Vol 98 (6) ◽

pp. 1094-1101 ◽

Cited By ~ 62

Author(s):

P McCall ◽

L K Gemmell ◽

R Mukherjee ◽

J M S Bartlett ◽

J Edwards

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Interim PSMA PET/CT Response Is Predictive of Survival of Prostate Cancer Patients Treatedwith Lu-177 PSMA DKFZ 617

10.1055/s-0040-1708395 ◽

2020 ◽

Author(s):

V Prasad ◽

K Huang ◽

N Czech ◽

S Prasad ◽

MR Makowski ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Psma Pet ◽

Pet Ct

Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy

Clinical & Translational Oncology ◽

10.1007/s12094-021-02553-5 ◽

2021 ◽

Author(s):

G. Ingrosso ◽

B. Detti ◽

A. Fodor ◽

S. Caini ◽

S. Borghesi ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Targeted Therapy ◽

Cancer Patients ◽

Stereotactic Ablative Radiotherapy ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients

Prostate Cancer and Prostatic Diseases ◽

10.1038/sj.pcan.4500752 ◽

2004 ◽

Vol 7 (4) ◽

pp. 350-354 ◽

Cited By ~ 17

Author(s):

P Rodrigues ◽

F Hering ◽

J C Campagnari

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Assessment of volumetric parameters derived from 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence

Nuclear Medicine Communications ◽

10.1097/mnm.0000000000001459 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Berna Okudan ◽

Nazim Coşkun ◽

Bedri Seven ◽

Merve Ağcioğlu Atalay ◽

Aslihan Yildirim ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Biochemical Recurrence ◽

Psma Pet ◽

Pet Ct

68Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy

Journal of Nuclear Medicine ◽

10.2967/jnumed.121.263006 ◽

2021 ◽

pp. jnumed.121.263006

Author(s):

Qaid Ahmed Shagera ◽

Carlos Artigas ◽

Ioannis Karfis ◽

Gabriela Critchi ◽

Nieves Martinez Chanza ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Metastatic Prostate Cancer ◽

Outcome Prediction ◽

Response Assessment ◽

Psma Pet ◽

Pet Ct

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases

Journal of Managed Care Pharmacy ◽

10.18553/jmcp.2012.18.1.74 ◽

2012 ◽

Vol 18 (1) ◽

pp. 74-75

Author(s):

Michael Rader ◽

Carsten Goessl ◽

Ze Cong

Keyword(s):

Prostate Cancer ◽

Economic Evaluation ◽

Zoledronic Acid ◽

Bone Metastases ◽

Cancer Patients ◽